Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Kircheis

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Metabolic Brain Disease|November 14, 2016
Current state of knowledge of hepatic encephalopathy (Part V): clinical efficacy of L-ornithine-L-aspartate in the management of HEGerald Kircheis
Journal of Gastroenterology and Hepatology|December 11, 2002
Management of hepatic encephalopathyGerald Kircheis, Dieter Häussinger
Drugs|February 2, 2019
Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic EncephalopathyGerald Kircheis, Stefan Lüth
Gut|July 13, 2013
Correct determination of critical flicker frequency is mandatory when comparisons to other tests are madeGerald Kircheis, Norbert Hilger, Dieter Häussinger
Journal of Gastroenterology and Hepatology|December 11, 2002
Pathogenesis of hepatic encephalopathyDieter Häussinger, Freimut Schliess, Gerald Kircheis
Gastroenterology|December 25, 2013
Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathyGerald Kircheis, Norbert Hilger, Dieter Häussinger
Gastroenterology|February 10, 2015
Reply: To PMID 24365582Gerald Kircheis, Norbert Hilger, Dieter Häussinger
Hepatology (Baltimore, Md.)|February 5, 2002
Critical flicker frequency for quantification of low-grade hepatic encephalopathyGerald Kircheis, Matthias Wettstein, Lars Timmermann, et al.
Journal of Hepatology|September 18, 2007
Assessment of low-grade hepatic encephalopathy: a critical analysisGerald Kircheis, Wolfgang E Fleig, Roman Görtelmeyer, et al.
Journal of Clinical and Experimental Hepatology|October 11, 2018
Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled TrialsRoger F Butterworth, Gerald Kircheis, Norbert Hilger, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Metabolic Brain Disease|November 14, 2016
Current state of knowledge of hepatic encephalopathy (Part V): clinical efficacy of L-ornithine-L-aspartate in the management of HEGerald Kircheis
Journal of Gastroenterology and Hepatology|December 11, 2002
Management of hepatic encephalopathyGerald Kircheis, Dieter Häussinger
Drugs|February 2, 2019
Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic EncephalopathyGerald Kircheis, Stefan Lüth
Gut|July 13, 2013
Correct determination of critical flicker frequency is mandatory when comparisons to other tests are madeGerald Kircheis, Norbert Hilger, Dieter Häussinger
Journal of Gastroenterology and Hepatology|December 11, 2002
Pathogenesis of hepatic encephalopathyDieter Häussinger, Freimut Schliess, Gerald Kircheis
Gastroenterology|December 25, 2013
Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathyGerald Kircheis, Norbert Hilger, Dieter Häussinger
Gastroenterology|February 10, 2015
Reply: To PMID 24365582Gerald Kircheis, Norbert Hilger, Dieter Häussinger
Hepatology (Baltimore, Md.)|February 5, 2002
Critical flicker frequency for quantification of low-grade hepatic encephalopathyGerald Kircheis, Matthias Wettstein, Lars Timmermann, et al.
Journal of Hepatology|September 18, 2007
Assessment of low-grade hepatic encephalopathy: a critical analysisGerald Kircheis, Wolfgang E Fleig, Roman Görtelmeyer, et al.
Journal of Clinical and Experimental Hepatology|October 11, 2018
Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled TrialsRoger F Butterworth, Gerald Kircheis, Norbert Hilger, et al.
Pageof 4